Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Acerta Pharma BV
University of Washington
City of Hope Medical Center
University of Washington
City of Hope Medical Center
Mayo Clinic
Celldex Therapeutics
Mayo Clinic
University Medical Center Groningen
Seagen Inc.
Merck Sharp & Dohme LLC
Abramson Cancer Center at Penn Medicine
Oslo University Hospital
University of Washington
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Ohio State University Comprehensive Cancer Center